[4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone
C110H123F4N19O16S4 — CID 159312865
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone
[4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone (PubChem CID 159312865) has the molecular formula C110H123F4N19O16S4 and a molecular weight of 2171.57 g/mol. Its IUPAC name is [4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone.
Molecular Properties
| Compound Name | [4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone |
|---|---|
| PubChem CID | 159312865 |
| Molecular Formula | C110H123F4N19O16S4 |
| Molecular Weight | 2171.57 g/mol |
| Exact Mass | 2169.82 |
| IUPAC Name | [4-(2,3-dimethylimidazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(1-methylpyrazol-3-yl)sulfonylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[4-(1,3-dimethylpyrazol-4-yl)sulfonyl-2,2-dimethylpiperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone;[2,2-dimethyl-4-(2H-pyrrol-4-ylsulfonyl)piperazin-1-yl]-[5-(4-fluorophenyl)-7-propan-2-ylfuro[3,2-b]pyridin-2-yl]methanone |
| SMILES | CC(C)c1cc(-c2ccc(F)cc2)nc2cc(C(=O)N3CCN(S(=O)(=O)C4=CCN=C4)CC3(C)C)oc12.CC(C)c1cc(-c2ccc(F)cc2)nc2cc(C(=O)N3CCN(S(=O)(=O)c4ccn(C)n4)CC3(C)C)oc12.Cc1ncc(S(=O)(=O)N2CCN(C(=O)c3cc4nc(-c5ccc(F)cc5)cc(C(C)C)c4o3)C(C)(C)C2)n1C.Cc1nn(C)cc1S(=O)(=O)N1CCN(C(=O)c2cc3nc(-c4ccc(F)cc4)cc(C(C)C)c3o2)C(C)(C)C1 |
| InChI | InChI=1S/2C28H32FN5O4S.C27H30FN5O4S.C27H29FN4O4S/c1-17(2)21-13-22(19-7-9-20(29)10-8-19)31-23-14-24(38-26(21)23)27(35)34-12-11-33(16-28(34,4)5)39(36,37)25-15-30-18(3)32(25)6;1-17(2)21-13-22(19-7-9-20(29)10-8-19)30-23-14-24(38-26(21)23)27(35)34-12-11-33(16-28(34,4)5)39(36,37)25-15-32(6)31-18(25)3;1-17(2)20-14-21(18-6-8-19(28)9-7-18)29-22-15-23(37-25(20)22)26(34)33-13-12-32(16-27(33,3)4)38(35,36)24-10-11-31(5)30-24;1-17(2)21-13-22(18-5-7-19(28)8-6-18)30-23-14-24(36-25(21)23)26(33)32-12-11-31(16-27(32,3)4)37(34,35)20-9-10-29-15-20/h2*7-10,13-15,17H,11-12,16H2,1-6H3;6-11,14-15,17H,12-13,16H2,1-5H3;5-9,13-15,17H,10-12,16H2,1-4H3 |
| InChIKey | LCTQIHIDAPXDQC-UHFFFAOYSA-N |
| XLogP | 18.46 |
| TPSA | 400.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 153 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2171.57 |
| LogP ≤ 5 | 18.46 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159312865 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.